Riskpilot← Back to searchSign inGet full accessBFL Clinic AB
ABActiveOrg 5592341506Aktervägen 2Beauty care and other beauty treatment activities · NACE 9622Est. 20191-4 employees
Revenue 2024
SEK 1,6M
+12% vs 2023
EBITDA margin
21.6%
+2% vs 2023
Equity ratio
49.6%
Financial strength
Net profit 2024
SEK 148K
+2% vs 2023
| Revenue | SEK 1,6M | +12% |
| EBITDA | SEK 339K | +2% |
| Net profit | SEK 148K | +2% |
| Total assets | SEK 898K | +19% |
| Equity | SEK 445K | -8% |
| Employees | — | — |
Legal name
BFL Clinic AB
Org number
5592341506
Legal form
Aktiebolag
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
27 december 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av ledamoten
Company purpose
Bolaget skall bedriva skönhetsvård inkluderande botoxinjektioner, fillers, mindre kosmetiska ingrepp och laserbehandling samt driva därmed förenlig verksamhet. Bolaget skall även äga och förvalta fast och lös egendom.
Address
Aktervägen 2
Email
drban2000@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 978 | 1 295 | 1 392 | 1 404 | 1 567 |
| Staff expenses | — | — | −244 | −289 | −460 |
| EBITDA | 615 | 185 | 497 | 331 | 339 |
| Depreciation & amort. | −0 | −113 | −116 | −147 | −147 |
| EBIT | 615 | 72 | 381 | 184 | 192 |
| Net financials | −1 | −2 | −1 | 2 | 0 |
| Profit before tax | 614 | 70 | 380 | 186 | 192 |
| Tax | −132 | −15 | −80 | −40 | −44 |
| Net profit | 482 | 55 | 301 | 146 | 148 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 065 | 767 | 977 | 752 | 898 |
| Equity | 532 | 417 | 718 | 484 | 445 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 532 | 350 | 259 | 269 | 453 |
| Total debt | 532 | 350 | 259 | 269 | 453 |
EBITDA margin
21.6%
This company
15.8%
Market median
+37% vs market
20202024
Equity ratio
49.6%
This company
38.2%
Market median
+30% vs market
20202024
Return on equity
33.4%
This company
18.4%
Market median
+82% vs market
20202024
Net profit margin
9.5%
This company
8.1%
Market median
+17% vs market
20202024
Asset turnover
1.75×
This company
1.12×
Market median
+56% vs market
20202024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2026 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2026 | |
| Chairman | 2021 – 2022 | |
| Chairman | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BFL Clinic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ban Abdel Haider | Chief Executive Officer | 0 companies |
| Zeinab Alkattan | Deputy Board Member | 0 companies |
| Shadan Wande | Chairman | 0 companies |
| Dulshaid Wande | Chairman | 0 companies |
| Emma Wande | Deputy Board Member | 0 companies |